RCUS
Price
$24.28
Change
+$1.10 (+4.75%)
Updated
Nov 25 closing price
Capitalization
3B
91 days until earnings call
Intraday BUY SELL Signals
TYRA
Price
$21.90
Change
-$0.36 (-1.62%)
Updated
Nov 25 closing price
Capitalization
1.17B
119 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RCUS vs TYRA

Header iconRCUS vs TYRA Comparison
Open Charts RCUS vs TYRABanner chart's image
Arcus Biosciences
Price$24.28
Change+$1.10 (+4.75%)
Volume$3.42M
Capitalization3B
Tyra Biosciences
Price$21.90
Change-$0.36 (-1.62%)
Volume$537.44K
Capitalization1.17B
RCUS vs TYRA Comparison Chart in %
RCUS
Daily Signal:
Gain/Loss:
TYRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RCUS vs. TYRA commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a StrongBuy and TYRA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 26, 2025
Stock price -- (RCUS: $24.28 vs. TYRA: $21.90)
Brand notoriety: RCUS and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 212% vs. TYRA: 173%
Market capitalization -- RCUS: $3B vs. TYRA: $1.17B
RCUS [@Biotechnology] is valued at $3B. TYRA’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $109.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, TYRA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 4 TA indicator(s) are bullish while TYRA’s TA Score has 4 bullish TA indicator(s).

  • RCUS’s TA Score: 4 bullish, 4 bearish.
  • TYRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RCUS and TYRA are a good buy in the short-term.

Price Growth

RCUS (@Biotechnology) experienced а +20.26% price change this week, while TYRA (@Biotechnology) price change was +36.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.10%. For the same industry, the average monthly price growth was -2.22%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

RCUS is expected to report earnings on Feb 25, 2026.

TYRA is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($3B) has a higher market cap than TYRA($1.17B). RCUS YTD gains are higher at: 63.062 vs. TYRA (57.554). TYRA has higher annual earnings (EBITDA): -121.07M vs. RCUS (-323M). RCUS has more cash in the bank: 831M vs. TYRA (296M). TYRA has less debt than RCUS: TYRA (6.02M) vs RCUS (111M). RCUS has higher revenues than TYRA: RCUS (240M) vs TYRA (0).
RCUSTYRARCUS / TYRA
Capitalization3B1.17B257%
EBITDA-323M-121.07M267%
Gain YTD63.06257.554110%
P/E RatioN/AN/A-
Revenue240M0-
Total Cash831M296M281%
Total Debt111M6.02M1,843%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSTYRA
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
80%
Bearish Trend 20 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signal:
Gain/Loss:
TYRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAEIX15.880.19
+1.21%
T. Rowe Price Overseas Stock Advisor
WBEIX15.450.13
+0.85%
William Blair Emerging Mkts Growth I
RYCHX185.07N/A
N/A
Rydex Technology C
QUAZX75.32N/A
N/A
AB Small Cap Growth Z
MSGAX12.11N/A
N/A
Meridian Small Cap Growth A

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+4.75%
XNCR - RCUS
55%
Loosely correlated
+3.11%
IDYA - RCUS
51%
Loosely correlated
+2.37%
IMNM - RCUS
50%
Loosely correlated
-1.88%
APGE - RCUS
49%
Loosely correlated
+4.52%
TYRA - RCUS
48%
Loosely correlated
-1.62%
More

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NRIX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-1.62%
NRIX - TYRA
54%
Loosely correlated
-0.87%
NUVL - TYRA
51%
Loosely correlated
+0.30%
XNCR - TYRA
47%
Loosely correlated
+3.11%
RCUS - TYRA
47%
Loosely correlated
+4.75%
KYMR - TYRA
46%
Loosely correlated
+0.69%
More